vs
Side-by-side financial comparison of Prenetics Global Ltd (PRE) and XBP Global Holdings, Inc. (XBP). Click either name above to swap in a different company.
XBP Global Holdings, Inc. is the larger business by last-quarter revenue ($152.4M vs $92.0M, roughly 1.7× Prenetics Global Ltd).
Prenetics (NASDAQ:PRE) is a health sciences company headquartered in Hong Kong, with a presence in the United States. It focuses on early detection, prevention, and treatment of diseases, particularly cancer.
PRE vs XBP — Head-to-Head
Income Statement — Q1 FY2023 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $92.0M | $152.4M |
| Net Profit | — | $-305.8M |
| Gross Margin | 39.2% | 21.7% |
| Operating Margin | — | -191.7% |
| Net Margin | — | -200.7% |
| Revenue YoY | — | -34.7% |
| Net Profit YoY | — | -980.1% |
| EPS (diluted) | — | $-2.60 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | — | $152.4M | ||
| Q3 24 | — | $233.4M | ||
| Q1 23 | $92.0M | — | ||
| Q3 22 | $74.7M | — | ||
| Q1 22 | $57.5M | — |
| Q3 25 | — | $-305.8M | ||
| Q3 24 | — | $-28.3M | ||
| Q1 23 | — | — | ||
| Q3 22 | — | — | ||
| Q1 22 | — | — |
| Q3 25 | — | 21.7% | ||
| Q3 24 | — | 18.9% | ||
| Q1 23 | 39.2% | — | ||
| Q3 22 | 34.5% | — | ||
| Q1 22 | 38.2% | — |
| Q3 25 | — | -191.7% | ||
| Q3 24 | — | 0.9% | ||
| Q1 23 | — | — | ||
| Q3 22 | -7.2% | — | ||
| Q1 22 | — | — |
| Q3 25 | — | -200.7% | ||
| Q3 24 | — | -12.1% | ||
| Q1 23 | — | — | ||
| Q3 22 | — | — | ||
| Q1 22 | — | — |
| Q3 25 | — | $-2.60 | ||
| Q3 24 | — | $-0.09 | ||
| Q1 23 | — | — | ||
| Q3 22 | — | — | ||
| Q1 22 | — | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $34.5M |
| Total DebtLower is stronger | — | $381.5M |
| Stockholders' EquityBook value | — | $130.5M |
| Total Assets | — | $947.9M |
| Debt / EquityLower = less leverage | — | 2.92× |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | — | $34.5M | ||
| Q3 24 | — | $7.8M | ||
| Q1 23 | — | — | ||
| Q3 22 | — | — | ||
| Q1 22 | — | — |
| Q3 25 | — | $381.5M | ||
| Q3 24 | — | $31.5M | ||
| Q1 23 | — | — | ||
| Q3 22 | — | — | ||
| Q1 22 | — | — |
| Q3 25 | — | $130.5M | ||
| Q3 24 | — | $-1.3B | ||
| Q1 23 | — | — | ||
| Q3 22 | — | — | ||
| Q1 22 | — | — |
| Q3 25 | — | $947.9M | ||
| Q3 24 | — | $99.6M | ||
| Q1 23 | — | — | ||
| Q3 22 | — | — | ||
| Q1 22 | — | — |
| Q3 25 | — | 2.92× | ||
| Q3 24 | — | — | ||
| Q1 23 | — | — | ||
| Q3 22 | — | — | ||
| Q1 22 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $13.9M |
| Free Cash FlowOCF − Capex | — | $10.5M |
| FCF MarginFCF / Revenue | — | 6.9% |
| Capex IntensityCapex / Revenue | — | 2.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | — | $13.9M | ||
| Q3 24 | — | $-1.5M | ||
| Q1 23 | — | — | ||
| Q3 22 | — | — | ||
| Q1 22 | — | — |
| Q3 25 | — | $10.5M | ||
| Q3 24 | — | $-6.1M | ||
| Q1 23 | — | — | ||
| Q3 22 | — | — | ||
| Q1 22 | — | — |
| Q3 25 | — | 6.9% | ||
| Q3 24 | — | -2.6% | ||
| Q1 23 | — | — | ||
| Q3 22 | — | — | ||
| Q1 22 | — | — |
| Q3 25 | — | 2.2% | ||
| Q3 24 | — | 2.0% | ||
| Q1 23 | — | — | ||
| Q3 22 | — | — | ||
| Q1 22 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PRE
Segment breakdown not available.
XBP
| Related And Non Related Party | $136.5M | 90% |
| Technology | $8.2M | 5% |
| Other | $5.7M | 4% |
| Deferred Revenue As Of July312025 | $1.9M | 1% |
